EpiQMAx GmbH

Biotechnology

  • Short facts

    • Research & Development
    • Service Provider
  • Year founded 2018
  • 4 Employees (site)
  • Turnover: <5m EUR

Products/services: EpiQMAx offers a full service for the quantitative analysis of epigenetic modifications by means of mass spectrometry. Since 2018, we are a partner for the development of epidrugs and biomarker research in the epigenetic field. Headquartered nearby Munich, we operate a state-of-the-art mass spectrometer to ultimately facilitate epigenetic screenings into clinical applications.

Basic data

Company

EpiQMAx GmbH

Street

Am Klopferspitz 19

PC / City

82152 Planegg

County

Upper Bavaria

Phone

+49 89-2153-5730

Language skills

Dutch, English, German, Spanish

Contact person

Management, Sales / marketing: Dr. Moritz Völker-Albert (Mr.)

Profile/competences

Core competencies

Our service is comprised of sample preparation, measurement and subsequent data analysis of epiegentic modifications. For sample preparation, we’ve developed a KIT that offers a standardized and cost-efficient preparation. With the help of mass spectrometry we solved the previous problems of the market and offer the analysis of combinations of modifications that cannot be solved by the competitors or alternative techniques. Finally, our service includes innovative software programs, which represent the real-time processing (tracking software), as well as an intuitive and visual reporting of our measurements (report software). In total, we are able to offer the fastest analytics service within the market.

Key sectors / sub-sectors

  • Biotechnology: Contract research (CROs) and contract manufacturing (CMOs)

NACE industries

  • Scientific research and development 72
  • Research and experimental development on natural sciences and engineering 72.1
  • Research and experimental development on biotechnology 72.11

Certifications

not available

Sales markets - target industries

Die weltweite Nachfrage nach diesem Service gilt für alle Pharmaunternehmen, die epigenetische Medikamente entwickeln und eine Zielvalidierung benötigen. Ebenso bieten wir unseren Service auch privaten Forschungsinstituten sowie klinischen Laboren an

Sales markets - target countries

Austria, Belgium, Denmark, Germany, Netherlands

Cooperation offers

not available